Calcineurin Mediates Synaptic Scaling Via Synaptic Trafficking of Ca2+-Permeable AMPA Receptors

Kim and Ziff examine the molecular mechanism of synaptic scaling, showing that inhibition of neuronal excitability reduces calcium influx into neurons, resulting in decreased calcineurin activity. This leads to increased surface expression of calcium-permeable AMPA receptors as a homeostatic response.


Introduction
Synaptic scaling, a form of homeostatic synaptic plasticity, is a negative feedback process that stabilizes neuronal activity in response to changes in synaptic strength by altering various aspects of neuronal function [1]. It has been implicated in neurodevelopment and in neurological disorders [2][3][4][5]. One of the mechanisms underlying synaptic scaling is the regulation of synaptic strength through control of delivery or retention of AMPARs at synapses [1]. During homeostatic adaptation, synaptic AMPARs are increased or reduced in response to activity deprivation or overexcitation, respectively, by altering AMPAR synaptic insertion and internalization [6]. Synaptic adaptation can be global and multiplicative, which is important for preserving the relative strength differences between synapses. Because each synapse strength is multiplied or divided by the same factor, each synaptic strength is increased or decreased in proportion to its initial strength [7]. Synaptic scaling is also induced by synapsespecific processes, providing local control of synaptic strength [8]. Numerous treatments that induce homeostatic regulation but differ in their experimental conditions have been reported. Nonetheless, the homeostatic plasticity mechanism is still not well understood. Here, we describe a novel mechanism in which activity deprivation induces synaptic scaling by a calcineurinmediated process.
The most studied experimental system for synaptic scaling is the inhibition of neuronal activity by TTX (tetrodotoxin), which blocks sodium channels and thereby inhibits action potentials. TTXdependent chronic inhibition of action potentials results in an increase in the strength of synaptic transmission as a compensatory process that can be measured by increases in AMPAR-mediated miniature excitatory postsynaptic currents (mEPSCs) [18]. Recent studies suggest that TTX reduces somatic Ca 2+ influx and inhibits activation of Ca 2+ /calmodulin-dependent protein kinase IV (CaMKIV), which promotes synaptic scaling [19]. CaMKs are important for Ca 2+dependent synaptic plasticity [20], and inhibition of Ca 2+ influx is sufficient to induce AMPAR-mediated synaptic scaling [21,22]. This suggests that reduction of CaMK activation and downstream signaling by activity deprivation-induced inhibition of Ca 2+ influx can play a critical role in AMPAR-dependent homeostatic scaling, yet there is no complete molecular mechanism linking activity-dependent Ca 2+ signals and homeostatic regulation of AMPARs.
Here, we focus on the role of synaptic Ca 2+ and calcineurin in synaptic scaling. We show that activity suppression reduces Ca 2+ influx in neurons, which in turn decreases the activity of calcineurin. This stabilizes pGluA1(S845), which increases synaptic CPARs. This increases synaptic strength as a compensatory response to activity deprivation and restores synapse-to-nucleus Ca 2+ signaling via ER Ca 2+ wave propagation. Thus, we conclude that synaptic scaling via calcineurin and CPARs provides a means to maintain not only synaptic activity but also Ca 2+ signaling as a homeostatic response.

TTX-Induced Multiplicative Synaptic Scaling Depends on CPARs
To confirm activity-dependent homeostatic scaling, we studied spontaneous synaptic transmission by measuring mEPSCs in DIV14-17 cultured mouse cortical neurons ( Figure 1a) and found that treatment for 48 h with 2 mM TTX significantly increased average mEPSC amplitude (no TTX, 19.6860.99 pA and 48 TTX, 28.0161.12 pA, p,.0001) (Figure 1b) consistent with the previous finding [23], whereas mEPSC frequency was not altered (Figure 1c). Importantly, cumulative probability distributions of the mEPSC amplitude were uniformly increased by TTX treatment, and the increase in the amplitude with TTX treatment was multiplicative (Figure 1e). There was a significant decrease in mEPSC decay time (peak to 10%) with TTX treatment (no TTX, 2.6660.15 ms and 48 TTX, 1.9860.05 ms, p = .0008) (Figure 1d). Because CPARs show a shorter decay time [21,24], we used 20 mM naspm (1-naphthyl acetyl spermine) or 5 mM PhTX (philanthotoxin-74), blockers of CPARs, to determine if CPARs were responsible for the TTX-mediated increase of the amplitude (Figure 1a). Consistent with previous findings [21,23,25] (Figure 1b), but frequency was not affected (Figure 1c). Naspm and PhTX also significantly increased decay time ( (Figure 1d) as found previously [21]. CPAR inhibitors had no effects on mEPSCs of neurons in the absence of TTX treatment, suggesting that CPARs made no contribution under the basal condition ( Figure 1). Thus, TTX treatment induced CPAR-mediated multiplicative synaptic scaling.

pGluA1(S845) Is Required for TTX-Induced Synaptic Scaling
Because pGluA1(S845) is required not only for homeostatic scaling in the visual cortex [26] but also for maintaining CPARs on the synaptic membrane [27], we measured the effects of TTX on pGluA1(S845) levels by purifying synaptosomes from TTXtreated neurons and measuring protein and phosphorylation levels of AMPAR subunits. TTX treatment significantly increased pGluA1(S845) (p = .024), whereas total GluA1 and GluA2/3 levels were not changed ( Figure 2a). We further determined that surface GluA1 levels were increased (p = .0127) after TTX treatment, whereas surface GluA2/3 was not altered (Figure 2b). We next analyzed mutant GluA1 (GluA1 S845A, unable to be phosphorylated on serine 845) using GluA1 S845A knock-in mice [28] and found that TTX treatment was unable to induce synaptic scaling in neurons from the mutant mouse ( Figure 2c). This suggested that TTX treatment enhanced GluA1 surface trafficking by increasing pGluA1(S845). This newly trafficked GluA1 could be in the form of CPARs that promote synaptic scaling.

TTX Treatment Reduces Calcineurin Activity in a Time-Dependent Manner
Increasing pGluA1(S845) can be achieved either by enhancing kinase activity or by decreasing phosphatase activity. A-kinase anchoring protein (AKAP) and SAP97 form a protein complex with GluA1 that tethers PKA and calcineurin, which regulate channel functions, respectively, through GluA1 phosphorylation and dephosphorylation [29,30]. Therefore, reduction of calcineurin activity is a candidate for mediating an increase of pGluA1(S845) in response to the TTX-induced reduction of Ca 2+ influx. We found that calcineurin protein levels were significantly decreased (p = .0414) in synaptosomes following TTX treatment (Figure 2a). To measure in vivo calcineurin activity directly, we used a fluorescence resonance energy transfer (FRET)-based

Author Summary
Synaptic scaling is a form of homeostatic plasticity that normalizes the strength of synapses (the structure that allows nerve cells to communicate) and is triggered by chronic inhibition of neuronal activity. Although extensive studies have been conducted, the molecular mechanism of this synaptic adaptation is not understood. Using cultured cortical neurons, we show that chronic inhibition of neuronal activity reduces calcium influx into neurons, which, in turn, decreases the activity of the calciumdependent phosphatase calcineurin. These changes lead to an increase in GluA1-containing, calcium-permeable AMPA receptors, which mediate communication at the synapse. Newly inserted calcium-permeable AMPA receptors restore calcium currents, which enhance synaptic strength and recover calcium signaling. We also show that inhibition or activation of calcineurin activity is sufficient to induce or block synaptic scaling, respectively, suggesting that calcineurin is an important mediator of homeostatic synaptic plasticity. Taken together, our findings show that synaptic scaling is a homeostatic process that not only enhances synaptic transmission but also maintains calcium signaling in neurons under activity deprivation.
calcineurin activity sensor that utilizes a calcineurin activitydependent molecular switch based on the N-terminal regulatory domain of nuclear factor of activated T cells (NFAT) as a specific substrate, which was inserted between CFP and YFP [31]. Inhibition of calcineurin activity by 12 h treatment with 5 mM FK506, which forms a drug-immunophilin complex that is a highly specific inhibitor for calcineurin [32], significantly decreased FRET activity (assayed by measuring the emission ratio) as compared with that under the basal condition (no TTX, 1.4560.02 and FK506, 1.0660.01, p,.0001), which confirmed that the reporter detected calcineurin activity ( Figure 3). Calcineurin activity was significantly decreased after 24 h TTX   (Figure 3). This suggested that chronic inhibition of neuronal activity decreased calcineurin activity in a time-dependent manner and lowered synaptic calcineurin levels.

Loss of Calcineurin Activity Is Sufficient to Induce CPAR-Dependent Synaptic Scaling in the Absence of TTX Treatment
Calcineurin inhibition affects both mEPSC frequency and amplitude [33,34] and stabilizes pGluA1(S845) [35], and reduction of cytoplasmic Ca 2+ lowers calcineurin activity, followed by enhancement of GluA1-containing AMPAR-mediated transmission [36]. To determine whether inhibition of calcineurin was sufficient for inducing a pharmacologic form of synaptic scaling in the absence of TTX treatment, we next blocked calcineurin activity by 12 h treatment with 5 mM FK506 and measured mEPSCs ( Figure 4a). FK506 treatment significantly increased mEPSC amplitude compared with DMSO treatment (DMSO, 20.3861.08 pA and FK506, 28.5461.41 pA, p,.0001) (Figure 4b). Consistent with a previous study showing that inhibition of calcineurin increases mEPSC frequency [33,34] through calcineurin modulation of presynaptic activity [37], we found increased mEPSC frequency in FK506-treated neurons (DMSO, 4.2160.37 Hz and FK506, 9.8860.27 Hz, p,.0001) ( Figure 4c). Furthermore, the mEPSC decay time in FK506treated neurons was significantly faster (DMSO, 2.5160.10 ms and FK506, 1.9660.10 ms, p = .0047), suggesting that CPARs mediated the scaling induced by FK506 ( Figure 4d). Moreover, cumulative probability distributions were uniformly shifted by FK506, and the increase in the amplitude was multiplicative ( Figure 4e). We confirmed CPAR-mediated scaling in FK506treated neurons by adding naspm or PhTX (Figure 4a), which caused a significant reduction of mEPSC amplitude (FK506, 28.5461.41 pA; FK506+naspm, 20.3161.14 pA, p,.0001; and FK506+PhTX, 19.3360.76 pA, p,.0001), whereas no effect was observed following naspm or PhTX treatment of DMSO-treated  (Figure 5a). These results indicated that inhibition of calcineurin by FK506 was sufficient to induce synaptic trafficking of CPARs by increasing pGluA1(S845) and that FK506 could produce a pharmacologic form of synaptic scaling without TTX-mediated activity deprivation.

Constitutively Active Calcineurin Mutant Inhibits TTX-Induced Synaptic Scaling
To test whether persistent calcineurin activity could block TTXmediated synaptic scaling, we generated a constitutively active calcineurin mutant, which has Ca 2+ -independent, constitutive phosphatase activity, by deleting the calcineurin autoinhibitory domain (CaN-DAI) [38]. As expected, when we cotransfected HEK293 cells with GluA1 and CaN-DAI, pGluA1(S845) levels were significantly lower (p = .0198) than in cells transfected with GluA1 alone (Ctrl) (Figure 6a). Although CaN-DAI decreased pGluA1(S845), surface GluA1 levels remained unaffected in cultured neurons ( Figure S1a). When CaN-DAI was cotransfected with GFP into neurons and we measured mEPSCs after 48 h TTX treatment, we found that TTX was unable to induce synaptic scaling in the presence of CaN-DAI (Figure 6b

Synaptic Scaling-Mediated Partial Homeostasis of Ca 2+ Signals
Ca 2+ signals are thought to be important for synaptic scaling, which suggests that a reduction of Ca 2+ influx may be a critical trigger for synaptic scaling [1,19,21,22]. Furthermore, lowering cytoplasmic Ca 2+ levels has been reported to enhance GluA1containing AMPAR-mediated transmission [36]. We investigated Ca 2+ activity in cultured neurons transfected with GCaMP5, a genetically encoded Ca 2+ indicator [39] (Figure 7a). We found active spontaneous Ca 2+ transients in neurons without TTX treatment (Figure 7b-c). To determine the effects of action potentials and mEPSC activity on Ca 2+ transients, we first added TTX at the time of imaging and found that acute TTX treatment completely blocked Ca 2+ activity (p,.0001) (Figure 7a-c). Furthermore, naspm treatment of neurons in the absence of TTX treatment had no significant effect on Ca 2+ transients (Figure 7a-c), suggesting that action potentials play a critical role in generating the Ca 2+ activity observed under these conditions, and that this activity is not dependent on CPARs. In contrast, following 48 h treatment with TTX, about 50% of the Ca 2+ signal was restored (p = .0002), and this restored activity observed in the presence of TTX was significantly reduced by naspm (p = .0079) (Figure 7a-c). This suggested that TTX-induced scaling provided a mechanism for maintaining Ca 2+ activity that was dependent in part upon the synaptic expression of CPARs.
We next investigated effects of calcineurin inhibition on Ca 2+ signals (Figure 8a). Neurons with 12 h DMSO treatment displayed normal Ca 2+ activity, and acute TTX treatment completely inhibited the activity (p,.0001) (Figure 8a-c). Neurons treated for 12 h with FK506 showed active spontaneous Ca 2+ transients comparable to those in neurons without TTX treatment (Figure 8a-c). Conversely, when TTX was acutely added at the time of imaging to neurons that had been treated for 12 h with FK506, TTX was unable to block the Ca 2+ signals completely (p = .005) (Figure 8a-c). To determine whether this Ca 2+ signal activity was mediated by CPARs, naspm was added to neurons at the time of recording (Figure 8a). Naspm significantly reduced the activity (p = .0069), indicating it was from CPARs (Figure 8a-c). Furthermore, we confirmed that CaN-DAI blocked synaptic scaling-mediated recovery of Ca 2+ signals (p,.0001) ( Figure  S1b), consistent with the finding that CaN-DAI inhibited TTXinduced synaptic scaling (Figure 6c). This suggested that calcineurin activity is important for both synaptic scaling and Ca 2+ homeostasis mediated by CPARs, which partially restored Ca 2+ signaling. Taken together, these results demonstrate that CPAR/calcineurin-dependent synaptic scaling provides a mechanism for homeostasis of Ca 2+ signals in part as a homeostatic response to activity deprivation-induced inhibition of Ca 2+ activity.
Synaptic Scaling Induced Ca 2+ Release from the ER and Maintained CREB Activity Both extracellular and intracellular sources of Ca 2+ are used by neurons [40]. Although Ca 2+ influx from extracellular sources is mediated by various Ca 2+ channels including NMDA receptors (NMDARs) at synapses and voltage-gated Ca 2+ channels in the plasma membrane, inositol 1,4,5-trisphosphate receptors (IP3Rs) and ryanodine receptors (RyRs) in the ER are responsible for intracellular Ca 2+ release [40]. We first investigated which Ca 2+ sources were responsible for GCaMP5-positive Ca 2+ signals (Figure 9a). To address this question, we blocked each Ca 2+ channel and measured spontaneous Ca 2+ signals without drug pretreatment (Figure 9a-b). When we acutely treated neurons with 10 mM nifedipine, an L-type Ca 2+ channel blocker, spontaneous Ca 2+ signals were unaltered, but the NMDAR antagonist, 50 mM APV, significantly reduced Ca 2+ activity (p,.0001), suggesting that GCaMP5 detected Ca 2+ signals including those from NMDARs but not from L-type Ca 2+ channels (Figure 9a-b). We next depleted Ca 2+ from the ER by inhibiting sarco/endoplasmic reticulum Ca 2+ -ATPase using 1 mM thapsigargin and found that thapsigargin treatment completely inhibited Ca 2+ activity (p, .0001) (Figure 9a-b). Moreover, blocking both IP3Rs and RyRs by 50 mM 2APB and 25 mM dantrolene significantly lowered Ca 2+ signals (p,.0001), suggesting that GCaMP5 detected Ca 2+ released from the ER, possibly dependent on the activity of NMDARs (Figure 9a-b). This further suggested that GCaMP5positive Ca 2+ signals restored by synaptic scaling were mediated by ER Ca 2+ release.
NMDAR-mediated synaptic Ca 2+ influx evokes Ca 2+ signals in the nucleus via Ca 2+ wave propagation through the ER [40]. This Ca 2+ signaling is essential for synaptic plasticity and regulates gene expression through CREB in addition to local signaling in synapses [40]. Because an NMDAR antagonist blocks CREB  activation [40] and CPARs also regulate ER Ca 2+ release [41], we hypothesized that CPARs replace the role of NMDARs in synapse-to-nucleus Ca 2+ signaling via the ER Ca 2+ release when neuronal activity is chronically suppressed by TTX. Consistent with previous findings [42,43], we found that CREB activity (assayed by measuring phosphorylation at serine 133 of CREB) was reduced with 6 h treatment of 2 mM TTX (p = .0004) or 1 mM thapsigargin (p = .0019), confirming that CREB activity was dependent on both neuronal activity and ER Ca 2+ (Figure 9c). However, after synaptic scaling was induced by 48 h treatment with TTX, CREB activity was significantly increased, suggesting that ER Ca 2+ signals restored by synaptic scaling provided a  means to maintain CREB phosphorylation in the nucleus (Figure 9c). Treatment with 20 mM naspm for 6 h significantly reduced the CREB phosphorylation seen in neurons pretreated with TTX for 48 h (p,.0001), suggesting CPARs were responsible for homeostasis of CREB phosphorylation (Figure 9c). Taken together, this work shows that when neuronal activity is suppressed by TTX, synaptic scaling maintains basal CREB activity via synapse-to-nucleus Ca 2+ signals by expression of CPARs at synapses and by ER Ca 2+ waves.

Discussion
We demonstrate a novel Ca 2+ homeostasis-dependent mechanism of synaptic scaling mediated by calcineurin and CPARs. Based on our findings, we propose the following model. Under basal conditions, action potentials provide synaptic Ca 2+ signals via NMDARs, followed by Ca 2+ -induced Ca 2+ release from the ER, leading to nuclear Ca 2+ signals that maintain CREBmediated transcriptional activity. In addition, synaptic Ca 2+ influx activates calcineurin, which removes GluA1 from the synaptic membrane by dephosphorylating pGluA1(S845), providing a balance between GluA1 insertion by kinases and removal by phosphatases in synapses ( Figure 10). However, under the condition of activity deprivation, NMDAR-mediated synaptic Ca 2+ influx is inhibited, leading to inactivation of calcineurin. This induces synaptic expression of CPARs via stabilization of pGluA1(S845), thereby enhancing synaptic strength and promoting synaptic Ca 2+ influx via CPARs instead of NMDARs ( Figure 10). This restores Ca 2+ signals and CREB phosphorylation and activation. We thus suggest that synaptic scaling not only maintains neuronal activity by increasing CPAR-dependent postsynaptic strength but also maintains CREB activation by synapse-to-nucleus Ca 2+ signaling.
Although it has been shown that postsynaptic AMPARs play a critical role in homeostatic synaptic plasticity, there is no generally agreed mechanism for synaptic scaling, possibly due to the fact that multiple experimental conditions have been investigated [13]. Many studies conducted in several experimental models support a role for this plasticity mediated by GluA1-containing AMPARs. For example, various protocols have been used to inhibit neuronal activity and induce synaptic scaling in cultured neurons, such as inhibition of action potentials by TTX [23], AMPARs by NBQX [21], L-type Ca 2+ channels by nifedipine [21], or NMDARs and action potentials together by APV and TTX [22]. Regardless of inhibition protocols, each treatment induced CPAR-dependent synaptic scaling. Furthermore, visual deprivation in the cortex is sufficient for inducing CPAR-dependent homeostatic synaptic plasticity in vivo [26]. Nonetheless, the cellular mechanism by which neurons detect activity deprivation and what is the molecular readout of this signal that regulates postsynaptic AMPARs for synaptic scaling has not yet been identified. A recent study by Gainey et al. employing GluA2 knockdown reports that GluA2 is required for homeostatic synaptic plasticity [44]. It is possible that the increased expression of synaptic CPARs that occurs in the GluA2 knockdown prior to addition of TTX increases synaptic Ca 2+ fluxes that prevent further CPAR synaptic trafficking required for synaptic scaling. In contrast, the GluA2 knockout exhibits normal synaptic scaling after chronic TTX treatment [45]. Significantly, in the knockout of GluA2, GluA1 levels at synapses are lower than in the wild type [46], a change which would generate significantly lower Ca 2+ flux than the knockdown, which in turn would make synaptic scaling possible. Given these considerations, the experimental findings of the others are consistent with the current work.
Ca 2+ influx in response to synaptic stimulation or action potentials plays an important role in regulating various neuronal functions including releasing neurotransmitter, modulating ion channels, and promoting synaptic plasticity and gene expression [47,48]. Somatic Ca 2+ levels are thought to be an important activity sensor in homeostatic synaptic plasticity [1,19,49]. Downstream effectors of Ca 2+ signaling including CaMKs and adenylyl cyclases can be molecular readouts of the Ca 2+ influx [13]. Because chronic neuronal inactivation reduces Ca 2+ influx and downregulates adenylnly cyclases [50], cAMP-dependent PKA activity is unlikely elevated by TTX to increase phosphorylation of S845 of GluA1, although it needs further investigation. Calcineurin is the only Ca 2+ /calmodulin-activated phosphatase in the brain, and it is a major regulator of several key proteins mediating synaptic transmission and neuronal excitability in both pre-and postsynaptic areas [51]. Due to the fact that calcineurin inhibition promotes an increase in both mEPSC frequency and amplitude, it has been proposed to have a role in homeostatic synaptic plasticity [33]. Moreover, lowering basal Ca 2+ levels has been shown to strengthen AMPAR-mediated transmission, which is dependent on GluA1 and calcineurin [36]. A computational modeling study predicts that calcineurin can be active at moderate Ca 2+ concentrations, whereas the activity of PKA requires high Ca 2+ levels [52]. It is thus possible that calcineurin can remain active in the short term, even after action potentials and synaptic Ca 2+ influx are abolished by TTX. Consistent with this study, we found that calcineurin activity was not reduced immediately after TTX treatment, and the reduction was found after a 24 h treatment with TTX ( Figure 3). This persistence of activity may explain why a significant length of time of application of TTX is required to express synaptic scaling. It has been shown that calcineurin inhibition increases pGluA1(S845) and selectively increases synaptic expression of CPARs [17]. Further investigation is required to determine how calcineurin inhibition selectively increases CPARs, given that it could potentially affect both GluA1 homomeric and GluA1/2 heteromeric AMPARs. We also showed that CaN-DAI was sufficient for reducing pGluA1(S845) levels, although surface GluA1 levels were not altered, which accounts for normal mEPSCs (Figure 6 and Figure S1a). Although it is not clear how normal levels of surface GluA1 are maintained when S845 phosphorylation is decreased, this is not surprising because several lines of studies already show that (1) there is normal synaptic transmission in the hippocampus of CaN-DAI overexpressed transgenic mice [53]; (2) in GluA1 S845A mutant mice, surface GluA1 levels are not affected [28]; and (3) GluA1 S845A mice also display normal mEPSCs in the amygdala [54]. Taken together, phosphorylation of GluA1 to yield pGluA1(S845) may not be critical for maintaining basal synaptic transmission, but can be important for activity-dependent plasticity, such as long-term potentiation or synaptic scaling.
It has been shown that lowering calcineurin activity with cyclosporin A, another calcineurin inhibitor, decreases not only enzymatic activity but also calcineurin protein levels [55], consistent with our findings (Figures 2a and 5a), suggesting that inactive calcineurin may be degraded. Neuronal activity regulates synaptic proteins and signaling through the ubiquitinproteasome system, providing a mechanism that links activity and protein turnover [56]. Ca 2+ entry is an important process regulated by neuronal activity that promotes a decrease of protein ubiquitination in synapses, which depends on calcineurin activity [57]. Calcineurin also can be ubiquitinated and undergo proteolysis in cardiomyocytes [58]. Thus, it is possible that chronic inhibition of neuronal activity decreases calcineurin activity by lowering Ca 2+ influx, which promotes increased protein ubiquitination, including ubiquitination of calcineurin itself, followed by proteasome-mediated degradation, although this requires further investigation.
During activity deprivation, synaptic Ca 2+ influx is reduced, possibly followed by inhibition of downstream Ca 2+ signaling [1,6,12]. Synaptic scaling may provide a mechanism to overcome these problems. GluA1-containing CPARs are an attractive candidate for restoration of Ca 2+ activity during synaptic scaling because unlike GluA2-containing, Ca 2+ -impermeable AMPARs, they not only have larger single channel conductance but also are Ca 2+ -permeable [59]. Based on our findings, we suggest that during homeostatic synaptic scaling, CPARs are stabilized in synapses and conduct Ca 2+ , which increases synaptic strength and also partially restores suppressed synaptic Ca 2+ signals as shown by the finding that GCaMP5 predominantly detected Ca 2+ release from the ER (Figures 7-9). In addition, cytosolic Ca 2+ levels may reflect neuronal activity on a cell-wide basis, permitting Ca 2+dependent mechanisms to control all synapses, a feature of multiplicative homeostatic synaptic plasticity. Therefore, recruitment of CPARs may provide feedback regulation to maintain neuronal activity and Ca 2+ signaling during synaptic scaling.
CaMKs are important for Ca 2+ -dependent synaptic plasticity, and reduction of CaMKIV activation is sufficient for inducting synaptic scaling without TTX treatment [19,20]. CaMKIVmediated activation of the CREB transcription factor is important for synaptic plasticity and learning [40]. Thus, it is possible that inhibition of CaMKIV activity reduces CREB activation and promotes synaptic scaling. Because the neuronal CREB transcription factor regulates various signaling pathways including those for learning, addiction, and pain [40], homeostasis of basal CREB activity can be important for brain function and may be maintained by synaptic scaling. Thus, synaptic scaling can provide a mechanism for maintaining basal levels of CREB-mediated transcriptional activity via synaptic Ca 2+ and CaMKIV when neuronal activity is suppressed. Our data support this idea by showing that (1) TTX inhibited somatic Ca 2+ signals, (2) TTX treatment reduced CREB phosphorylation, and (3) synaptic scaling restored Ca 2+ signaling and CREB activation.
In summary, we conclude that synaptic scaling not only maintains neuronal stability by increasing CPAR-dependent postsynaptic strength but also maintains basal CREB transcriptional activity through nuclear Ca 2+ signaling as a homeostatic response to suppression of neuronal activity.

Mouse Cortical Neuron Cultures and Neuronal Transfection
Cortical primary neurons were prepared by a modification of the previously described method [60]. Neurons were isolated from embryonic day 17-18 C57Bl6 or GluA1 S845A mouse embryonic brain tissues. All animal studies were performed with an approved protocol from New York University Langone Medical Center's Institutional Animal Care and Use Committee. Neurons were plated on poly-L-lysine-coated 15 cm dishes for biochemical experiments, size 12 mm cover glasses for electrophysiology and FRET assay, or glass-bottom dishes for Ca 2+ imaging. Cells were grown in Neurobasal medium with B27 and 0.5 mM Glutamax (Life Technologies). For neuronal transfection, DIV4 neurons were transfected with Lipofectamine 2000 (Life Technologies) according to the manufacturer's protocol, and analysis was performed at DIV14-17.

Generation of Constitutively Active Calcineurin Mutant
Constitutively active calcineurin mutant (CaN-DAI) was generated according to the previous study [38]. A stop codon was introduced at lysine 399 of wild-type murine calcineurin alpha (Addgene, 17871) to produce CaN-DAI that lacked the calmodulin-binding and autoinhibitory domains, leading to Ca 2+ -independent, constitutive phosphatase activity [38]. CaN-DAI was cotransfected with GluA1 into HEK293 cells using Lipofectamine 2000 (Life Technologies) to confirm expression and pGluA1(S845) levels by immunoblots. For surface GluA1 leveling, CaN-DAI was cotransfected with mCherry into neurons, and surface GluA1 was determined by incubation of a GluA1 antibody (Calbiochem, PC246) under the nonpermeable condition. The Alexa Fluor-488 secondary antibody (Molecular Probes, A-11008) was used to visualize surface GluA1, and proximal dendrites (,100 mm from the cell body) were captured using Zeiss Axiovert 200 m. Images were analyzed by the ImageJ software.

FRET-Based Calcineurin Activity Assay
Neurons were transfected with the calcineurin activity biosensor, and FRET activity was measured at DIV14 according to a modification of the previously described method [31]. Neurons were pretreated with 2 mM TTX for 12, 24, or 48 h, or 5 mM FK506 for 12 h, and fixed with 4% paraformaldehyde. Images were captured by using Applied Precision PersonalDV live-cell imaging system in the Microscopy Core of New York University Langone Medical Center. The following formula was used to calculate the emission ratio: Yellow À to À Cyan emission ratio( FRET channel emission intensity À FRET channel emission intensity of background)= (CFP channel emission intensity À CFP channel emission intensity of background): Pseudocolor images of the emission ratio were generated by using the ImageJ software, as previously reported [62].

Ca 2+ Imaging
DIV4 neurons were transfected with GCaMP5 (Addgene, 31788). Neurons were grown for 10-12 d after transfection in Neurobasal medium without phenol red and supplemented with B27 and 0.5 mM Glutamax. Glass-bottom dishes were mounted on a temperature-controlled stage on Zeiss Axiovert 200M and maintained at 37uC and 5% CO 2 using a Zeiss stage incubator model S with CTI, digital temperature, and humidity controller. The imaging was captured for periods of 0.5 to 1.0 s depending on the intensity of the fluorescence signal using a 636 oil-immersion objective. One hundred images were obtained with a 1-s interval, and Ca 2+ activity in the cell body (excluding dendrites) was analyzed using the ImageJ software. F 0 was determined as the minimum value during the imaging. Total Ca 2+ activity was obtained by combining 100 values of DF/F 0 = (F t 2F 0 )/F 0 in each image, and values of DF/F 0 ,0.3 were rejected due to bleaching.

Statistics
Most statistical comparisons were analyzed with the GraphPad Prism6 software. Unpaired two-tailed Student's t tests were used in single comparisons. For multiple comparisons, we used one-way analysis of variance (ANOVA) followed by Fisher's Least Significant Difference (LSD) test to determine statistical significance. The Kolmogorov-Smirnov (K-S) test (http://www.physics. csbsju.edu/stats/KS-test.html) was used for comparisons of cumulative probabilities. Results were represented as mean 6 s.e.m., and a p value,.05 was considered statistically significant. Figure S1 Effects of CaN-DAI on surface GluA1 and Ca 2+ activity. (a) Representative images of GluA1 surface labeling (green) and mCherry were used as markers for transfection (red) (n = number of cells). Scale bar is 2 mm. A summary graph of surface GluA1 levels in each condition. (b) Example bar graphs of Ca 2+ activity in each condition. Each bar represents the GCaMP5 fluorescence intensity detected in a single exposure frame. Scale bars are 50 s. Normalized average of total Ca 2+ activity in each condition (n = number of neurons, **p,.01 and ****p,.0001, oneway ANOVA, uncorrected Fisher's LSD). (TIF)